
14 Oct 2025
The GLP-1 Revolution: How Obesity Drugs Are Reshaping Pharma Economics
How GLP-1 receptor agonists have moved from niche diabetes treatments into a wider commercial and supply-chain force across pharma.
Cardiovascular systemDiabetesOncology



